BioCryst Pharmaceuticals ... (BCRX)
BioCryst Pharmaceuticals Max Pain By Strike
BCRX trades at $7.63, 4.6% below the near-term max pain of $8 expiring Oct 17, 2025 (19 days). Price stability likely with balanced options positioning at this level. Max pain is stable across expirations ($5-$10), indicating stable market expectations. Key magnetic zone at 8 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
BioCryst Pharmaceuticals Max Pain By Expiry
Max pain for BCRX shows stable levels around 7.33, reflecting balanced market expectations. The 68% spread signals divergent expectations across timeframes. Levels distributed around 7.63. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Oct 17, 2025 | 8 | n/a (n/a) |
| Nov 21, 2025 | 6 | n/a (n/a) |
| Dec 19, 2025 | 8 | n/a (n/a) |
| Jan 16, 2026 | 7 | n/a (n/a) |
| Mar 20, 2026 | 10 | n/a (n/a) |
| Jan 15, 2027 | 5 | n/a (n/a) |